Ca 19-9 in the monitoring of colorectal cancer after surgery

被引：0
|
作者：
F. Franchi
C. Pastore
P. Izzo
E. Calió
机构：
[1] University of Rome ‘La Sapienza’,Department of Clinical Medicine, Oncology Unit
[2] University ‘Tor Vergata’,Department of Obstetrics and Gynecology
来源：
Medical Oncology | 2001年 / 18卷
关键词：
Colorectal cancer; CEA; Ca 19-9; marker sensitivity/specificity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：237 / 238
页数：1
相关论文
共 50 条
  • [21] CA 19-9 IN THE DIAGNOSIS OF GASTRIC AND COLORECTAL-CARCINOMA
    SAFI, F
    BITTNER, R
    POOS, R
    ROSCHER, R
    BEGER, HG
    MEDIZINISCHE KLINIK, 1985, 80 (23) : 676 - 679
  • [22] CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer
    Yasasever, V
    Oral, EN
    Camlica, H
    Dalay, N
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 27 - 32
  • [23] CA 19-9 AS A PROGNOSTIC INDEX AFTER RESECTION FOR PANCREATIC-CANCER
    SPERTI, C
    PASQUALI, C
    CATALINI, S
    CAPPELLAZZO, F
    BONADIMANI, B
    BEHBOO, R
    PEDRAZZOLI, S
    JOURNAL OF SURGICAL ONCOLOGY, 1993, 52 (03) : 137 - 141
  • [24] CA 19-9: Not a magic marker for pancreatic cancer
    Daram, Sumanth R.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (03) : 205 - 205
  • [25] CA 19-9 and Lewis Antigens in Pancreatic Cancer
    Atkins, Carl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2572 - 2573
  • [26] Is CA 19-9 useful in the management of pancreatic cancer?
    Balzano, Gianpaolo
    Di Carlo, Valerio
    LANCET ONCOLOGY, 2008, 9 (02): : 89 - 91
  • [27] CA 19-9 and carcinoembryonic antigen in gallbladder cancer
    deAretxabala, X
    Riedeman, JP
    Roa, I
    Wenzel, C
    Inostroza, J
    Burgos, L
    Araya, JC
    Siegel, S
    Millaqueo, L
    Espinoza, R
    REVISTA MEDICA DE CHILE, 1996, 124 (01) : 11 - 20
  • [28] Exploiting the relevance of CA 19-9 in pancreatic cancer
    Salleh, Syaza
    Thyagarajan, Anita
    Sahu, Ravi P.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [29] CEA, CA 242, CA 19-9, CA 72-4 and hCGβ in the diagnosis of recurrent colorectal cancer
    Carpelan-Holmström, M
    Louhimo, J
    Stenman, UH
    Alfthan, H
    Järvinen, H
    Haglund, C
    TUMOR BIOLOGY, 2004, 25 (5-6) : 228 - 234
  • [30] CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma
    Pectasides, D
    Mylonakis, A
    Kostopoulou, M
    Papadopoulou, M
    Triantafillis, D
    Varthalitis, J
    Dimitriades, M
    Athanassiou, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 348 - 353
12345